Clinical trial
Adipose Inflammation and Diabetes (FAB)
Recruiting now · Not applicable · 1 countries · Registry ID NCT04255264
Recruiting nowNot applicableObservational
What this study is about
The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to 60 Years
SexAll
Healthy volunteersNot listed
ConditionObese
Full registry criteria
Inclusion Criteria: * BMI 30-40 kg/m2 * Ptos (i.e. excess skin) \> 3 cm * Patient underwent gastric bypass surgery \>2 years ago * Patient has had a stable weight ≥6 months at the time of operation * Patient does not smoke (min 6 weeks prior to surgery) Exclusion Criteria: * Patients who do not understand spoken and written Swedish * American Society of Anesthesiologists (ASA) classification ≥ 3 * Neurological, orthopedic or rheumatologic injury or illness affecting physical ability * Preoperatively known hernia requiring surgical operation * Severe mental illness
Treatments and study arms
The registry does not list a named intervention.
Primary outcomes
Inflammatory status2025
The inflammatory status will be studied in obese patients.
Study locations
1 locations were listed when this page was built. The first 40 are shown.
Sahlgrenska university hospital🇸🇪 Gothenburg, Västra Götaland County, Sweden
Emma Borgeson, PhDContact